Viewpoint discusses disease identification and molecular mechanisms in cystic fibrosis, highlighting treatment advances.
In this Viewpoint, 2025 Lasker-DeBakey Clinical Medical Research Award winner Michael J. Welsh describes his contributions to cystic fibrosis (CF) disease identification, understanding the cellular and molecular basis of CF, and development of a highly effective triple-drug treatment.
No takes yet. Share an insight, caveat, or question.
Michael J. Welsh (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: